Therapeutic Solutions International Inc (TSOI)
0.0006
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Therapeutic Solutions International Enterprise Value: 3.429M for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 3.429M |
| April 22, 2024 | 3.852M |
| April 19, 2024 | 3.852M |
| April 18, 2024 | 3.852M |
| April 17, 2024 | 3.852M |
| April 16, 2024 | 4.171M |
| April 15, 2024 | 4.364M |
| April 12, 2024 | 3.785M |
| April 11, 2024 | 3.978M |
| April 10, 2024 | 3.978M |
| April 09, 2024 | 3.785M |
| April 08, 2024 | 3.978M |
| April 05, 2024 | 4.364M |
| April 04, 2024 | 4.171M |
| April 03, 2024 | 4.364M |
| April 02, 2024 | 3.978M |
| April 01, 2024 | 5.136M |
| March 28, 2024 | 4.750M |
| March 27, 2024 | 4.557M |
| March 26, 2024 | 4.364M |
| March 25, 2024 | 4.557M |
| March 22, 2024 | 3.978M |
| March 21, 2024 | 4.364M |
| March 20, 2024 | 3.978M |
| March 19, 2024 | 3.978M |
| Date | Value |
|---|---|
| March 18, 2024 | 4.171M |
| March 15, 2024 | 4.364M |
| March 14, 2024 | 4.750M |
| March 13, 2024 | 4.750M |
| March 12, 2024 | 4.750M |
| March 11, 2024 | 4.750M |
| March 08, 2024 | 5.136M |
| March 07, 2024 | 4.750M |
| March 06, 2024 | 4.750M |
| March 05, 2024 | 5.329M |
| March 04, 2024 | 5.522M |
| March 01, 2024 | 4.750M |
| February 29, 2024 | 4.364M |
| February 28, 2024 | 4.364M |
| February 27, 2024 | 4.171M |
| February 26, 2024 | 4.943M |
| February 23, 2024 | 4.364M |
| February 22, 2024 | 4.557M |
| February 21, 2024 | 4.750M |
| February 20, 2024 | 4.943M |
| February 16, 2024 | 5.136M |
| February 15, 2024 | 5.136M |
| February 14, 2024 | 5.329M |
| February 13, 2024 | 4.750M |
| February 12, 2024 | 5.329M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.650M
Minimum
Nov 12 2019
335.79M
Maximum
Feb 11 2021
38.60M
Average
14.22M
Median
Dec 17 2020
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.275M |
| Palatin Technologies Inc | 18.75M |
| iBio Inc | 16.49M |
| Theriva Biologics Inc | -13.75M |
| Oragenics Inc | 3.306M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.4275M |
| Revenue (Quarterly) | 0.0238M |
| Total Expenses (Quarterly) | 0.5806M |
| EPS Diluted (Quarterly) | -0.0001 |
| Gross Profit Margin (Quarterly) | 55.73% |
| Profit Margin (Quarterly) | -1.79K% |
| Earnings Yield | -114.8% |
| Normalized Earnings Yield | -120.50 |